ACTIVATION OF PROCARCINOGENS BY GLUTATHIONE CONJUGATION
Project Number5F32CA080376-02
Contact PI/Project LeaderWHEELER, JAMES B
Awardee OrganizationVANDERBILT UNIVERSITY
Description
Abstract Text
Industrial compounds such as methylene chloride, dibromoethane, and
butadiene are known carcinogens in rodents. These compounds are
activated by conjugation with glutathione (GSH) and cause mutations in
DNA by forming DNA adducts. The intermediates of this reaction are
believed to be glutathione conjugates formed by glutathione S-
transferases (GSTs). This proposal compares the ability of rat, human,
and bacterial GSTs to form mutagenic DNA adducts with GSH conjugates in
the presence of different haloalkanes and butadiene diepoxide. The
proposed research will examine the genotoxicity of these compounds, the
mechanism of activation by GST, the stability of the compounds, and the
DNA adducts formed. The Ames test will be used to determine the
mutagenicity of the various compounds when GST is being expressed in
Salmonella typhuurium. Recombinant GSTs from human, rat and bacterial
sources will be purified and used for in vitro assays to determine the
mechanism of DNA adduct formation. Chemically synthesized intermediates
of the GSH activation reaction will be tested for stability under
various conditions and oligonucleotides will be used to test the
formation of DNA adducts.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA damageSalmonella typhimuriumadductcarcinogenschemical conjugatechemical synthesisenzyme mechanismglutathione transferasehaloalkanemutagen testingmutagensoligonucleotidesprotein purification
No Sub Projects information available for 5F32CA080376-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F32CA080376-02
Patents
No Patents information available for 5F32CA080376-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F32CA080376-02
Clinical Studies
No Clinical Studies information available for 5F32CA080376-02
News and More
Related News Releases
No news release information available for 5F32CA080376-02
History
No Historical information available for 5F32CA080376-02
Similar Projects
No Similar Projects information available for 5F32CA080376-02